Aflibercept after failed intravitreal bevacizumab may be effective in radiation retinopathy

Results of a pilot study suggest that patients with radiation retinopathy may respond to intravitreal aflibercept after failed monthly bevacizumab. Researchers evaluated visual acuity (VA) and central foveal thickness (CFT) responses in 30 patients with radiation retinopathy after switching to aflibercept. At 1 month, 3 months, and 6 months following...